The Sodium-Iodide Symporter
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
167-174
Author(s):
C. H. Baker and J. C. Morris
Chromogranin A in Tumors: More Than a Marker for Diagnosis and Prognosis
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
4
Page:
161-168
Author(s):
Angelo Corti and Elisabetta Ferrero
The Use of Nitric Oxide Synthase Inhibitors in Inflammatory Diseases: A Novel Class of Anti-Inflammatory Agents
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
3
Page:
271-301
Author(s):
Bahar Tunctan and Sedat Altug
Antitumor Pharmacology - Quo Vadis ?
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
389-391
Author(s):
Christian Bailly, Jean-Marc Barret and Anna Kruczynski
Monoclonal Antibodies in Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
411-414
Author(s):
Barbara Gatto
Camptothecins and Topoisomerase I; A Foot in the Door. Targeting the Genome Beyond Topoisomerase I with Camptothecins and Novel Anticancer Drugs; Importance of DNA Replication, Repair and Cell Cycle Checkpoints
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
429-434
Author(s):
Yves Pommier
Novel Oncogenic Protein Kinase Inhibitors for Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
449-455
Author(s):
Tomi K. Sawyer
p53: Fighting Cancer
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
385-402
Author(s):
Galina Selivanova
Novel Strategies in Cancer Therapeutics: Targeting Enzymes Involved in Cell Cycle Regulation and Cellular Proliferation
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
403-424
Author(s):
M. C. Liu, J. L. Marshall and R. G. Pestell
Carcinoembryonic Antigen as a Target to Induce Anti-Tumor Immune Responses
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
443-454
Author(s):
P. Sarobe, E. Huarte, J. J. Lasarte and F. Borras-Cuesta